Navigation Links
Adult stem cell application effective in treatment of peripheric vascular disease
Date:1/24/2008

Multipotent adult progenitor stem cells extracted from bone marrow, and known as MAPCs, have proved to be effective in the regeneration of blood vessel tissue and also in muscle tissue when treating peripheric vascular disease. This was the result of research undertaken with mouse models by two research groups, one by the University Hospital of Navarra jointly with the Centre for Applied Medical Research (CIMA), also of the University of Navarra, and the other by the Centre for Molecular and Vascular Biology atthe Catholic University of Leuven (Belgium).

The results of the study have been recently published as an article in The Journal of Clinical Investigation the main author of which is doctor in Biology at the University Hospital of the University of Navarra and CIMA, Xabier Lpez Aranguren. The study was part of a line of research for his PhD thesis. The directors of the current research are doctors Felipe Prsper, for the University Hospital of Navarra and CIMA and Aernout Luttun and Catherine M. Verfaille for the Catholic University of Leuven.

Aim of research

Acute peripheric vascular disease involves the obstruction of the blood circulation in a determined area of the organism, as a consequence of the occlusion of the artery supplying blood to it, with the consequent reduction in blood flow. If it is not treated in time, the ischemia can cause various complications; the worst scenario being tissue necrosis, gangrene, or even the loss of an affected limb. In any case, the basic effect of peripheric ischemia is an important loss of vascularisation in the affected area, as well as in the musculature.

The research work published in The Journal of Clinical Investigation analysed the role and potential of two different types of cell-based treatments for peripheric vascular disease. It was based on the use of experimental mice models that were treated for this blood vessel ailment using MAPC cells implant and mononucleate cells from bone marrow.

MAPCs are multipotent adult progenitor stem cells obtained from bone marrow and which have a capacity for proliferating and differentiating in multiple tissues and which, thereby, comply with the criteria to be stem cells. The mononucleate cells from bone marrow are also a set of cells the hematies and plaques of which have been simply suppressed and, so, include stem cells but also differentiated cells such as monocytes and lymphocytes.

The study aimed to compare the efficacy of both cell populations in the treatment of peripheric ischemia given that the use of marrowbone cells for treatment of patients is currently being considered. Consequently, it is important to determine if there could be differences in the efficacy between the two types of cells.

The interest of the research lies in that the trunk cells analysed were not implanted in the same state as they were extracted. Also observed was the role that they might play when, before being transplanted, they are pre-differentiated into the concrete types of cell required. In this way, the idea was to see if greater benefit accrues from transplanting the cells just as they are extracted or if it is preferable to carry this out after differentiation has been achieved.

Results

The most important finding from the research was that adult MAPC stem cells are more effective when injected without pre-differentiation, not only because they contribute in increasing the quantity of arteries and veins generated in the new area, but also because they manage to enhance muscle regeneration. Although it is true that the muscle regenerates mainly thanks to an indirect phenomenon, not because the stem cells are differentiated in muscle cells, but because they help the muscle grow more and better as a consequence of secreting a series of substances. The research thus concluded that the MAPC progenitor cells implanted in mice achieved an indirect improvement of the muscle and a direct enhancement of the vessels.

On the other hand, the study also showed that, although the mononucleate cells are capable of regenerating in the short or medium term, the vascularisation of the mice damaged by the ischemia may have a negative effect in the long term. This is because transplanting mononucleate cells into the limbs of mice generate greater fibrosis with time. This conclusion has given rise to a certain degree of controversy as regards a number of current clinical studies that propose the use of mononucleate cells from bone marrow.

Human MAPCs and those of the mouse

The study was carried out on both cell populations from mice as well as humans. During the research the team from the University Hospital at the University of Navarra and CIMA was responsible for the experiments with human cells, while the University of Leuven team was in charge of the tests with mice cells.

Analysing the results from both models, the same degree of efficacy was observed, to such an extent that the experiments undertaken with MAPCs from mice and those from humans overlap, i.e. they both achieve identical benefits.


'/>"/>

Contact: Egoitz Etxebeste
egoitz@elhuyar.com
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. Air pollution linked to cardiovascular risk indices in healthy young adults
2. Urban Smog Tough on Young Adults Hearts
3. Heart Attacks at School Involve More Adults Than Kids
4. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
5. Computer-Related Eye Strain Not Just for Adults
6. Adult offspring of parents with PTSD have lower cortisol levels
7. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
8. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
9. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
10. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
11. Stem cells derived from adult testes produce wide range of tissue types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Salt Lake City, UT (PRWEB) , ... February 05, 2016 , ... ... Activz Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, ... Really Cool Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... addition of micro-needling services in their Napa Valley office. The technique utilizes the ... Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a select ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the ... to wait longer to access the treadmills. It’s a predictable trend. After the excesses ... weight and get in shape by joining gyms, starting new walking or running routines, ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  Edwards Lifesciences Corporation ... innovations for structural heart disease and critical care monitoring, ... share repurchase (ASR) agreement with Morgan Stanley & Co. ... This repurchase is part of the Company,s previously authorized ... Company,s common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... filed in the United States District Court for the District ... class (the "Class") consisting of all persons or entities who ... "Company") (NASDAQ: INSY ) from March 3, 2015 through ... and certain of its officers with violations of the Securities ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  Montoya Love ... Professional in the field of Pharmaceuticals. Montoya is the ... Manufacturing ... supplies, Becton Dickinson provides healthcare institutions, clinical ... equipment throughout fifty countries across the globe. ...
Breaking Medicine Technology: